Brain Projects springing up across the world: The B.R.A.I.N. Initiative, The Human Brain Project (HBP) and Israel Brain Technologies

R&D budgets across the world have surprisingly struggled to take serious note of neuro-science’s explosive growth, and neurotech briefly remained under-funded, awaiting a policy push. Until recently, that is. Today, at least five international neuroscience initiatives are already going full-steam ahead towards a brighter neurotech future, all of which are less than three years old. The initiatives are in addition to ambitious brain projects and specialized neuroscience foundations and non-profit organizations around the world, some of which were established precisely to relieve R&D budget bottlenecks.

Israel’s President Shimon Peres was one of the first global leaders to see the immense potential of neurotechnology and to lay foundations for Israel’s now burgeoning Israel Brain Technologies initiative, officially founded in 2011. Many figures and organizations quickly followed suit, in what has now become a global gold rush to fill the emerging power vacuum on the throne of world brain leaders. Table 1 summarizes active neuroscience initiatives and active brain foundations around the world.

TABLE 1. A SELECTION OF GLOBAL NEUROSCIENCE INITIATIVES AND FOUNDATIONS

Initiative/ Foundation	Country	Est.	Budget		Goals/Objectives/Focus
INITIATIVES
Brain Research Through Advancing Innovative Technologies (B.R.A.I.N)	USA	2013	$100 million for first year; commitment for 10 years—subsequent budget to be drawn at later stages	Create an elaborate brain map and invest in novel brain mapping technologies
Fattah Brain Initiative (Now part of B.R.A.I.N)	USA	2011		Significantly increase federal funding of neuroscience, which the initiative accomplished  with the B.R.A.I.N. project
Human Brain Project	EU	2013	€1.19 billion over 10 years	Develop world’s most elaborate ICT (Information and Communication Technology) Infrastructure in order to provide powerful research tools for neuroscience and to establish and accelerate a global collaboration in brain research
Israel Brain Technologies (IBT)	Israel	2011	N/A; $1 million prize for international innovative neurotechnology	Make Israel a leading neurotech hub of the world; fund most innovative global neuro-technologies
National Neurotechnology Initiative Act (NNTI)	USA	2007	$200 million	Open up innovation bottlenecks by coordinating across federal agencies on all neuro-developments, and establishing multi-agency cooperation in neuroscience
Brain Canada Multi-Investigator Research Initiative (MIRI)	Canada	2012	CA$ 1.5 million per project, over three years	Support up to five multidisciplinary teams in the sphere of neuroscience research over three years

Palestinian Neuroscience Initiative	Palestine	2010	Approx. $300,000	Build infrastructure for neuroscience research in Palestine, Augment research training for a new generation of Palestinian medical students and doctors, in cooperation with elite institutions worldwide
NORBRAIN – NORWAY BRAIN INITIATIVE	Norway	2012	NOK 80 million (US $13.7 million)	Set up state-of-the-art neuroscience equipment across a broad spectrum of molecular and systems neuroscience in Norway
FOUNDATIONS
The Dana Foundation*	USA	1950	Approx. $10 million revenue (2011)	Advance brain research and educate the public in a responsible manner about research’s potential
The Brain Canada Foundation (Brain Canada)†	Canada	2010	CA$100 million	Support Canadian neuroscience, accelerate discoveries to improve the health and quality of life for Canadians who suffer from brain disorders
The Israel Society For Neuroscience#	Israel	1992	N/A	Collect, share and disseminate information about Israel’s neuro-developments
Brain Foundation Australia#	Australia	1970	N/A	Fund world-class research Australia-wide into neurological disorders, brain disease and brain injuries
Global Neuroscience Initiative Foundation (GNIF)#	USA	2003	N/A	Advance neurological and mental health patient welfare, education, and research; promote free and open-access distribution of brain related information

* Private philanthropic organization

† National charitable organization

# Non-profit charity organization

THE B.R.A.I.N INITIATIVE

On April 2, 2013 President Barack Obama unveiled the BRAIN (which coincidentally spells Brain Research through Advancing Innovative Neurotechnologies) initiative, whose final and uttermost objective is to visualize, map, understand and reconstruct the activity of every single neuron in the brain. This knowledge will in the future be applied to the development of new technologies and the treatment of quickly expanding array of neurological disorders.

The initiative was launched with US$ 100 million in the President’s Fiscal Year 2014 Budget, which pales in comparison with the $5.5 billion the NIH spends on neuroscience annually, but significantly outshines the measly $28 million spent on the human genome project in its first year of operation. BRAIN’s near-sighted primary goal will be to sponsor ongoing brain mapping projects, such as the Human Connectome Project, and technologies which will facilitate the projects’ progress. In his BRAIN inauguration speech, the President called on academic institutions, industry, foundations, researchers and philanthropists to help in identifying realistic goals and objectives for the initiative.

In addition to the governmental budget, philanthropic and non-profit organizations have made additional support pledges to the initiative. Foundations which have already announced dedicated commitment to the plan and related projects are: The Allen Institute ($60 million), the Howard Hughes Medical Institute ($30 million annually), the Kavli Foundation ($4 million annually) and Salk Institute for Biological Studies ($28 million).

Considering the fact that a single Human Connectome Project brain scan consumes 22MW of electricity – enough to power a nuclear submarine, BRAIN is likely to be costlier than previous initiatives, and will need to carry a substantial focus on making technological leaps in altogether new directions, which are certainly needed in order to progress with the world’s exuberant plans.

Amongst the plans the BRAIN Initiative advocates are:

• Solid academic expertise: NIH is due to form an academic leadership group comprising leading scientists to lay out clear scientific objectives, milestones, cost estimates and timetables for the initiative.
• Strong academia-industry collaboration: federal agencies are strongly encouraged to partner with companies and foundations with complementary interests, paving the way for a smooth transition from neuro-science to neuro-tech. In the past, such collaborations have strongly benefitted government plans, and feature prominently in the BRAIN initiative. All the US-based foundations and initiatives described in table 2 are expected to work closely with the BRAIN initiative.
• High ethical standards: because neuroscientific, or generally breakthrough, practices are likely to touch on ethically-sensitive bases at some point, the BRAIN initiative is preliminarily addressing potential issues via the President’s order to the Commission for the Study of Bioethical Issues for efforts to be partially diverted towards foreseeable or arising challenges in light of society, the law and ethics.

THE HUMAN BRAIN PROJECT

Since the Human Brain Project’s (HBP) inception in 2013 in its birthplace Lausanne, proponents have likened it to the CERN for the brain, whilst opponents have called it a flamboyant, and a much too feathery, peacock of the sciences. The ambitions of the project are so grand that the necessary supercomputer, befittingly titled “The Brain”, whose job would be to simulate the inner workings of CNS headquarters, would take at least 12 years to build, and each neuron it would simulate would guzzle the power of one laptop. The Brain would devour every neuroscientific finding, brain scan, neuroanatomical image and other imaginable parameters around the world, and process all that information to potentially recreate the millions of neurons and synapses of the mind, and simulate their behavior.

The Human Brain Project competed with other, no less ambitious projects, for the modest sum of €1.19 billion over the next ten years. One worthy challenger project, which also managed to secure substantial EU funds, was 21^st century’s miracle material graphene. In general, the main goal of HBP is to slowly but steadily simulate every human brain neuron on the computer, and HBP’s founder and, incidentally, Israel’s Weizmann Institute graduate Henry Markram plans to accomplish this by the 2040s. Work towards this objective is already underway: HBP’s prototype, titled the Blue Brain Project, was launched by Markram in 2005 and by 2008 the first artificial neocortical column of 10,000 rat brain cells was complete.  By 2011 the number of simulated rat neocortical columns stood at 100, and the rat brain project is due to be completed in 2014. By the way, the $20 million supercomputer on which the Blue Brain Project runs costs $1 million a year to cool with Lake Geneva’s water. So much for simulating an organ which runs on the energy of a bedside lamp.

The human brain is orders of magnitude more complex than the rat brain, but perhaps the most restricting factor in human brain simulation is the fact that humans do not grow in labs, and neuroscientists are faced with the immense quest of creating a unique approach to collecting human brain data without having to genetically modify or dissect homo sapiens. This is why HBP will be an omnipotent cohort of 150 (soon to be 1,500) top researchers from 70 institutions in 22 countries, whose reach will branch far and wide into the depths of the scientific and healthcare communities.

The chaotic complexity of HBP is undeniable, but the team has broken the monster mission into manageable and very relevant parts. There is the Neuroinformatics Platform, which aims to create a practical interface for scientists around the world to share and homogenize their data, and the Brain Simulation Platform which will make use and most importantly sense of the collected information, and perform in silico research. Then there are the High Performance Computing Platform, the Medical Informatics Platform, the Neuromorphic Computing Platform and a Neurorobotics Platform. The platforms are all based on previous pioneering work by the partners and, within 30 months, will be open for use by the world’s neuroscience community, growing in magnitude from continuous input generated from research.

And then there is the ethical and public awareness committee, whose important role is to present latest findings to the public so as to minimize the project’s ability to cause unwarranted panic and misunderstanding, to the possibility of which genetically modified produce could testify.

ISRAEL BRAIN TECHNOLOGIES

Israel is often referred to as the “Start-up Nation”, but Israel’s president Shimon Peres is seemingly fascinated by a much further frontier than that. From “Start-up Nation” to “Brain Nation” is how the recent non-profit Israel Brain Technologies (IBT) initiative is commonly described. The main goal of the initiative will be to steer Israel’s immense R&D efforts in a more neuro-inspired direction, carrying the ultimate goal of making Israel a leading neurotech hub of the world.

The initiative was conceived under President Peres’s firm belief in the future of neurotechnology, but was put in motion by one of the most successful entrepreneurs in Israel’s history—Dr Rafi Gidron, who was the official founder of IBT and now serves as its chairman. Gidron founded an optical component company Chromatis in 1998, and sold the company to Lucent just 27 months later for $4.7 billion, in what has since become Israel’s largest exit.

Gidron strongly supports the President’s vision to turn Israel into the go-to neuro nation. After all, Peres was able to raise $250 million for nanotechnology research, and there isn’t a doubt that he could do the same for neurotech. IBT is now entering its third year of operation, and already over $10 million was raised for areas which form the focus of the initiative: human-machine interface and neurological therapies.

Currently IBT is generating hype through its $1 million prize offered for yet another brain acronym--the B.R.A.I.N. (Breakthrough Research And Innovation in Neurotechnology) competition, which will see most promising scientists around the globe lock horns over who will be the creator of the most innovative technology around the world in the following spheres:

• Technology for diagnostics and treatment of brain disease
• Technology which can improve scientific understanding of the brain
• Groundbreaking brain-machine interface technology
• Innovative brain stimulation technology
• Disruptive neuro-technologies in computation, robotics and communications

Currently a team of leading researchers and neuro-experts around the globe, which include three Nobel laureates Profs Eric Kandel, Daniel Kahneman and Bert Sakmann, are selecting amogst a number of finalists of the Brain Prize, which were announced in May of 2013. The winner will be revealed at IBT’s Global Brain Technology conference in October 2013.

More info at www.IsraelBrain.org

From Start-up Nation to Brain Nation: Interview with Israel Brain Technologies founder Dr Rafi Gidron

“Our brain enabled us to produce artificial brains, but did not permit us to enter our own brains. We are strangers to ourselves.”

“Israel lives on its brain. We’re now embarking on the fourth revolution. The first were the agricultural, industrial and information revolutions, and now comes the revolution of the brain. This is a problem that Israel devotes itself to solving as quickly as possible and as strongly as possible. Israel is well-positioned to assume a leadership role in the emerging neurotechnology industry that promises to make the world a better place”

                                                                                 -Israel's President Shimon Peres, 2011
                     

Israel is often referred to as the “Start-up Nation”, but Israel’s president Shimon Peres is seemingly fascinated by a much further frontier than that. From “Start-up Nation” to “Brain Nation” is how the recent non-profit Israel Brain Technologies (IBT) initiative is commonly described. The main goal of the initiative will be to steer Israel’s immense R&D efforts in a more neuro-inspired direction, carrying the ultimate goal of making Israel a leading neurotech hub of the world. 

The initiative was conceived under President Peres’s firm belief in the future of neurotechnology, but was put in motion by one of the most successful entrepreneurs in Israel’s history—Dr Rafi Gidron, who was the official founder of IBT and now serves as its chairman. Gidron founded an optical component company Chromatis in 1998, and sold the company to Lucent just 27 months later for $4.7 billion, in what has since become Israel’s largest exit. 

Gidron strongly supports the President’s vision to turn Israel into the go-to neuro nation. After all, Peres was able to raise $250 million for nanotechnology research, and there isn’t a doubt that he could do the same for neurotech. IBT is now entering its third year of operation, and already over $10 million was raised for areas which form the focus of the initiative: human-machine interface and neurological therapies. 

Currently IBT is generating hype through its $1 million prize offered for yet another brain acronym--the B.R.A.I.N. (Breakthrough Research And Innovation in Neurotechnology) competition, which will see most promising scientists around the globe lock horns over who will be the creator of the most innovative technology around the world in the following spheres:

• Technology for diagnostics and treatment of brain disease
• 
  
• Technology which can improve scientific understanding of the brain
• 
  
• Groundbreaking brain-machine interface technology
• 
  
• Innovative brain stimulation technology
• 
  
• Disruptive neuro-technologies in computation, robotics and communications

Currently a team of leading researchers and neuro-experts around the globe, which include three Nobel laureates Profs Eric Kandel, Daniel Kahneman and Bert Sakmann, are selecting a number of finalists of the Brain Prize, which are to be announced in May of 2013. The winner will be revealed at IBT’s Global Brain Technology conference in October 2013. 

More info at www.IsraelBrain.org

Interview with IBT founder Dr Rafi Gidron

Dr Rafi Gidron may be best known for having orchestrated Israel’s largest start-up exit, but today this serial entrepreneur, angel investor and Columbia PhD graduate holds the key to success of the country’s newest vision: to reenact Israel’s hi-tech triumphs, with neurotechnology as the lead star. Dr Gidron has helped assemble an elite multi-disciplinary team of experts who will be responsible for advancing the Israeli neuro-dream. As IBT chairman he is responsible for moving forward the vision that was inspired by President Shimon Peres, by establishing IBT’s infrastructure and objectives, and building sound financial support around the initiative. A key role which IBT is expected to play is being the mediator between international investors and Israeli technologies, and well as various global foundations and Israeli academia. 

One could almost say Dr Gidron was reared for the role of IBT founder: as an avid brain enthusiast for over 10 years he studied the field in depth, and, during the fruitful time of nanotechnology circa 2003, he was involved in Pres. Shimon Peres’s initiative to advance Israel’s nanotech arena. When Pres. Peres’s vision of Israeli neurotech surfaced, Gidron, having accumulated a wealth of entrepreneurial insight and acumen, instantly saw the opportunity. Like Israel’s president, Dr Gidron agrees that neurotechnology is the ultimate challenge, and the ultimate opportunity, of the 21st century. It just so happens that Israel is excellently positioned to be a globally impacting winner in this space, provided that its journey is in the right hands (it is, trust us). 

IBT B.R.A.I.N. Prize finalists are to be announced on May 15th, and winners in October 2013 at IBT’s first-of-a-kind Global Brain Technologies Conference. The project has received over 70 applications: ~40% from the US, ~30% from Israel, ~20% from Europe, and the remainder from the rest of the world. Dr Gidron hopes that this project will bring the world to Israeli brain technology, and Israeli brain technology to the world. In addition to the $1 million prize, the winning project will gain the support of IBT, which will continue as a close cooperation to develop the world’s next breakthrough. For IBT, the B.R.A.I.N. competition will demonstrate Israel’s ability to become a hub connecting and accelerating global neuro-technologies. 

Dr Gidron says that IBT is still in preliminary stages of development, but its chief priorities are to support and nurture the nascent neurotech industry through whatever means possible. As IBT gathers momentum, it continues to attract industry leaders and academic and public sector experts. As of today, two Nobel laureates are already part of IBT’s scientific board. One of the developments which Dr Gidron would like to see in the future is the establishment of a neurotech development facility in Israel by a large multinational corporation (MNC), which would contribute to the country’s impressively high MNC presence in other industries. 

Asked about whether the IBT will be looking to cooperate with other world brain initiatives, like the Human Brain Project and the B.R.A.I.N, Dr Gidron said that this will form an integral part of the mission, and added that he is very excited to see other world leaders share the neurotech vision. He says that collaboration between the IBT and the HBP is currently in the works.

Like many experts in the field, Dr Gidron acknowledges that Israel possesses a particular strength in medical devices, which is why IBT isolated key areas of focus with a particular sway in that direction. In his opinion, the burgeoning defense industry, a strong track record in technological innovation, a vibrant culture of entrepreneurship and risk-taking and the multidisciplinarity of all aspects of life in Israel contribute to its unique edge and its quirky inimitability. 

Dr Gidron ends with a sound bite, “Israel: It's not only a State of Mind. It’s a State of Brain!”. And, in retrospect, perhaps another reason for Israel’s enigmatic success is precisely people like him.